Search research articles
Contact Us
Filters
Showing results (1-10 of 52) with videos related to
Page
of 6
Sort By:
Journal of Clinical Pharmacology
|
March 9, 2016
Reply to: Letter to the Editor "Effect of Quinidine, a Strong P-Glycoprotein Inhibitor, on the Pharmacokinetics and Central Nervous System Distribution of Naloxegol"
Nidal Al-Huniti
Clinical Pharmacology in Drug Development
|
May 3, 2019
Population Pharmacokinetic Modeling and Probability of Target Attainment Analyses in Asian Patients With Community-Acquired Pneumonia Treated With Ceftaroline Fosamil
Jianguo Li, Shampa Das, Diansong Zhou, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
March 21, 2018
Assessing QT/QTc interval prolongation with concentration-QT modeling for Phase I studies: impact of computational platforms, model structures and confidence interval calculation methods
Jingtao Lu, Jianguo Li, Gabriel Helmlinger, et al.
Antimicrobial Agents and Chemotherapy
|
August 29, 2018
Simplified Aztreonam Dosing in Patients with End-Stage Renal Disease: Results of a Monte Carlo Simulation
Alan E Gross, Hongmei Xu, Diansong Zhou, et al.
Journal of Clinical Pharmacology
|
May 16, 2015
Population pharmacokinetic modeling of quetiapine after administration of seroquel and seroquel XR formulations to Western and Chinese patients with schizophrenia, schizoaffective disorder, or bipolar disorder
Diansong Zhou, Khanh H Bui, Jianguo Li, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
January 11, 2020
Modeling Tumor Growth and Treatment Resistance Dynamics Characterizes Different Response to Gefitinib or Chemotherapy in Non-Small Cell Lung Cancer
Mario Nagase, Sergey Aksenov, Hong Yan, et al.
British Journal of Clinical Pharmacology
|
February 19, 2017
Population pharmacokinetic and exposure simulation analysis for cediranib (AZD2171) in pooled Phase I/II studies in patients with cancer
Jianguo Li, Nidal Al-Huniti, Anja Henningsson, et al.
Journal of Clinical Pharmacology
|
August 18, 2016
Evaluation of Aztreonam Dosing Regimens in Patients With Normal and Impaired Renal Function: A Population Pharmacokinetic Modeling and Monte Carlo Simulation Analysis
Hongmei Xu, Wangda Zhou, Diansong Zhou, et al.
Primary Care Respiratory Journal : Journal of the General Practice Airways Group
|
March 24, 2007
Clinical and therapeutic variables influencing hospitalisation for bronchiolitis in a community-based paediatric group practice
Baha Al-Shawwa, Nidal Al-Huniti, Miles Weinberger, et al.
British Journal of Clinical Pharmacology
|
December 24, 2017
Population exposure-safety analysis of cediranib for Phase I and II studies in patients with cancer
Nidal Al-Huniti, Klas Petersson, Weifeng Tang, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 52) with videos related to
Sort By:
Page
of 6
Journal of Clinical Pharmacology
|
March 9, 2016
Reply to: Letter to the Editor "Effect of Quinidine, a Strong P-Glycoprotein Inhibitor, on the Pharmacokinetics and Central Nervous System Distribution of Naloxegol"
Nidal Al-Huniti
Clinical Pharmacology in Drug Development
|
May 3, 2019
Population Pharmacokinetic Modeling and Probability of Target Attainment Analyses in Asian Patients With Community-Acquired Pneumonia Treated With Ceftaroline Fosamil
Jianguo Li, Shampa Das, Diansong Zhou, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
March 21, 2018
Assessing QT/QTc interval prolongation with concentration-QT modeling for Phase I studies: impact of computational platforms, model structures and confidence interval calculation methods
Jingtao Lu, Jianguo Li, Gabriel Helmlinger, et al.
Antimicrobial Agents and Chemotherapy
|
August 29, 2018
Simplified Aztreonam Dosing in Patients with End-Stage Renal Disease: Results of a Monte Carlo Simulation
Alan E Gross, Hongmei Xu, Diansong Zhou, et al.
Journal of Clinical Pharmacology
|
May 16, 2015
Population pharmacokinetic modeling of quetiapine after administration of seroquel and seroquel XR formulations to Western and Chinese patients with schizophrenia, schizoaffective disorder, or bipolar disorder
Diansong Zhou, Khanh H Bui, Jianguo Li, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
January 11, 2020
Modeling Tumor Growth and Treatment Resistance Dynamics Characterizes Different Response to Gefitinib or Chemotherapy in Non-Small Cell Lung Cancer
Mario Nagase, Sergey Aksenov, Hong Yan, et al.
British Journal of Clinical Pharmacology
|
February 19, 2017
Population pharmacokinetic and exposure simulation analysis for cediranib (AZD2171) in pooled Phase I/II studies in patients with cancer
Jianguo Li, Nidal Al-Huniti, Anja Henningsson, et al.
Journal of Clinical Pharmacology
|
August 18, 2016
Evaluation of Aztreonam Dosing Regimens in Patients With Normal and Impaired Renal Function: A Population Pharmacokinetic Modeling and Monte Carlo Simulation Analysis
Hongmei Xu, Wangda Zhou, Diansong Zhou, et al.
Primary Care Respiratory Journal : Journal of the General Practice Airways Group
|
March 24, 2007
Clinical and therapeutic variables influencing hospitalisation for bronchiolitis in a community-based paediatric group practice
Baha Al-Shawwa, Nidal Al-Huniti, Miles Weinberger, et al.
British Journal of Clinical Pharmacology
|
December 24, 2017
Population exposure-safety analysis of cediranib for Phase I and II studies in patients with cancer
Nidal Al-Huniti, Klas Petersson, Weifeng Tang, et al.
Page
of 6